FDA Inspection 1153683 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006468609

The FDA completed an inspection of Octapharma Plasma, Inc. on September 23, 2021 in Wichita, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 23, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wichita, KS (United States)